Kura Oncology CEO Troy Wilson's 2020 pay jumps 30% to $4.2M
Kura Oncology reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
Kura Oncology reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, six executives at Kura Oncology received on average a compensation package of $2.6M, a 3% increase compared to previous year.
Average pay of disclosed executives at Kura Oncology
Troy E. Wilson, Chief Executive Officer, received $4.2M in total, which increased by 30% compared to 2019. 73% of Wilson's compensation, or $3.1M, was in option awards. Wilson also received $441K in non-equity incentive plan, $573K in salary, as well as $99K in other compensation.
For fiscal year 2020, the median employee pay was $346,674 at Kura Oncology. Therefore, the ratio of Troy E. Wilson's pay to the median employee pay was 12 to one.
Stephen Dale, Chief Medical Officer, received a compensation package of $3.3M. 88% of the compensation package, or $2.9M, was in option awards.
Kirsten Flowers, Chief Commercial Officer, earned $2.9M in 2020.
Bridget Martell, M.A., Chief Medical Officer, received $2.4M in 2020.
Marc Grasso, Chief Financial Officer, earned $1.6M in 2020, a 25% decrease compared to previous year.
Kathleen Ford, Chief Operating Officer, received $1M in 2020, which decreases by 70% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2021.